Status:
UNKNOWN
Implant Placement With Corticocancellous Bone Block vs Mineralized Plasmatic Matrix in Maxillary Sinus Lifting
Lead Sponsor:
Cairo University
Conditions:
Maxillary Sinus Floor Elevation
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
Maxillary sinus floor elevation is a predictable and effective procedure for increasing the height of the residual bone in the posterior maxilla. The sinus lift procedure is basically performed using ...
Detailed Description
After meeting the inclusion criteria, A preoperative digital panoramic radiograph with 1:1 magnification will be taken for each patient as a primary survey in order to exclude the presence of any lesi...
Eligibility Criteria
Inclusion
- Patients with edentulous vertically deficient posterior maxillary ridge with remaining alveolar ridge bone height \<4=/ mm.
- Both males as well as females without any active periodontal disease.
- All patients are in a good health with no systemic, immunologic, or debilitating diseases that could affect normal bone healing.
- Patients are free from T.M.J troubles, abnormal oral habits such as bruxism.
- The edentulous ridges are covered with optimal thickness of mucoperiosteum with no signs of inflammation, ulceration or scar tissue.
- Remaining natural teeth have good periodontal tissue support and occlusion showed sufficient inter arch space for future prosthesis.
Exclusion
- On the local level, patients with maxillary sinus diseases, former sinus surgery and unfavorable inter maxillary relationship will be excluded.
- General contraindications to implant surgery.
- Remaining ridges\>5mm
- Subjected to irradiation in the head and neck area less than 1 year before implantation.
- Untreated periodontitis.
- Poor oral hygiene and motivation.
- Pregnant or nursing.
- Substance abuse/smoking.
- Psychiatric problems or unrealistic expectations.
- Severe bruxism or clenching.
- Treated or under treatment with intravenous amino-bisphosphonates.
- Lack of opposite occluding dentition/prosthesis in the area intended for implant placement.
- Active infection, current or previous pathology or severe inflammation in the area intended for implant placement.
- Need of bone augmentation procedures at implant placement site.
- Unable to open mouth sufficiently to accommodate the surgical tooling.
- Patients participating in other studies, if the present protocol could not be properly followed.
- Referred only for implant placement or unable to attend a 1-year follow-up.
Key Trial Info
Start Date :
December 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2024
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT06073912
Start Date
December 1 2023
End Date
June 1 2024
Last Update
October 10 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.